Corbus Pharmaceuticals
CRBP
#10362
Rank
NZ$77.59 M
Marketcap
NZ$3.77
Share price
-15.40%
Change (1 day)
-82.39%
Change (1 year)

Earnings for Corbus Pharmaceuticals (CRBP)

Earnings in 2026 (TTM): -NZ$0.19 Billion

According to Corbus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.16 Billion a decrease over its 2024 earnings that were of -NZ$70.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corbus Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.19 Billion20.05%
2025 -NZ$0.16 Billion116.04%
2024 -NZ$70.09 Million-14.54%
2023 -NZ$82.01 Million28.56%
2022 -NZ$63.79 Million-37.68%
2021 -NZ$0.11 Billion-54.41%
2020 -NZ$0.23 Billion59.28%
2019 -NZ$0.15 Billion35.87%
2018 -NZ$0.11 Billion74.27%
2017 -NZ$59.53 Million62.94%
2016 -NZ$36.54 Million125.82%
2015 -NZ$16.18 Million251.68%
2014 -NZ$4.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Viking Therapeutics
VKTX
-NZ$1.15 Billion 500.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-NZ$0.33 Billion 70.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Epizyme
EPZM
-NZ$0.34 Billion 75.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-NZ$62.2 Million-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA